Wordt geladen...
Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma
Sorafenib is an oral multiple kinase inhibitor that blocks Raf, vascular endothelial growth factor receptor, and platelet-derived growth factor receptor. It has been approved in the US and Europe for the treatment of advanced hepatocellular carcinoma (HCC). Sorafenib has demonstrated a 44% increase...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3846497/ https://ncbi.nlm.nih.gov/pubmed/24367212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/HMER.S7123 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|